Skip to content
CorpDev.Org

CorpDev.Org

Deal Intelligence Platform & Services for Global M&A / PE

Saturday 13th June 2026
  • AI Diligence Platform
  • Expert Deal Services
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities
  • About CorpDev.Org
  • Editorial Standards
CorpDev.Org

CorpDev.Org

Deal Intelligence Platform & Services for Global M&A / PE

  • AI Diligence Platform
  • Expert Deal Services
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities
  • About CorpDev.Org
  • Editorial Standards

Category: Deal Drama

BlackRock’s Private Equity Struggles: Lessons, Competitors, and a Path Forward

BlackRock’s Private Equity Struggles: Lessons, Competitors, and a Path Forward

  • January 13, 2025
  • 0 Comments
  • By Vyas Tungaturti
Underperformance Woes: BlackRock's private equity division has faced significant challenges, with declining assets under management (AUM) due to poor fund performance and market volatility....
Posted in Deal Drama, Private Equity
DOJ Blocks Amex GBT’s $570M CWT Buyout Over Antitrust Concerns

DOJ Blocks Amex GBT’s $570M CWT Buyout Over Antitrust Concerns

  • January 13, 2025
  • 0 Comments
  • By Vyas Tungaturti
Antitrust Lawsuit: The U.S. Department of Justice has filed a civil antitrust lawsuit to block American Express Global Business Travel's (GBT) proposed $570 million acquisition of rival CWT, citing...
Posted in Big Deal, Deal Drama, Financial Services
AbbVie’s $1.4B Alzheimer’s Bet: Game Changer or Risky Gamble?

AbbVie’s $1.4B Alzheimer’s Bet: Game Changer or Risky Gamble?

  • October 29, 2024
  • 0 Comments
  • By Vyas Tungaturti
Strategic Acquisition: AbbVie's $1.4 billion acquisition of Aliada Therapeutics signals a significant bet on Alzheimer's disease treatment, bolstering its pipeline with a Phase I anti-amyloid...
Posted in Deal Drama, Healthcare and Life Sciences
Luxury Merger Blocked: Tapestry-Capri Deal Faces Antitrust Setback

Luxury Merger Blocked: Tapestry-Capri Deal Faces Antitrust Setback

  • October 27, 2024
  • 0 Comments
  • By Vyas Tungaturti
Antitrust Scrutiny: The blocked $8.5 billion Tapestry-Capri merger highlights increasing antitrust scrutiny in the luxury fashion industry, as regulators aim to protect consumer interests and...
Posted in Consumer and Industrial, Deal Drama
Carlyle Retreats from Thyssenkrupp Defence Bid: Berlin’s Regulatory Uncertainty Impacts M&A

Carlyle Retreats from Thyssenkrupp Defence Bid: Berlin’s Regulatory Uncertainty Impacts M&A

  • October 27, 2024
  • 0 Comments
  • By Vyas Tungaturti
Regulatory Hurdles: Carlyle Group's withdrawal from bidding for Thyssenkrupp's defence unit highlights the significant regulatory challenges in Germany's defence industry M&A landscape. Strategic...
Posted in Big Deal, Consumer and Industrial, Deal Drama
FTC Probes Boeing’s $4.7B Spirit Aero Buy: Antitrust Fears and Industry Impact

FTC Probes Boeing’s $4.7B Spirit Aero Buy: Antitrust Fears and Industry Impact

  • October 27, 2024
  • 0 Comments
  • By Vyas Tungaturti
Strategic Acquisition: Boeing's $4.7 billion all-stock acquisition of Spirit AeroSystems aims to improve aircraft quality and safety by integrating Spirit's operations. Regulatory Scrutiny: The...
Posted in Consumer and Industrial, Deal Drama
Rookie plays merger arbitrage; lands in legal soup with Reliance

Rookie plays merger arbitrage; lands in legal soup with Reliance

  • October 24, 2024
  • 0 Comments
  • By Vyas Tungaturti
In the bustling streets of Delhi, a young app developer’s aspiration to study at the University of Cambridge has led him into a legal standoff with Reliance Industries over the domain name...
Posted in Deal Drama, Technology, Media and Telecom
Roche vs. Novo-Catalent Deal: Shaping Pharma’s Competitive Future

Roche vs. Novo-Catalent Deal: Shaping Pharma’s Competitive Future

  • October 24, 2024
  • 0 Comments
  • By Vyas Tungaturti
Competitive Landscape: Roche CEO Thomas Schinecker urges regulators to block Novo Holdings' $16.5B acquisition of Catalent, citing concerns over reduced competition and potential negative impacts on...
Posted in Deal Drama, Healthcare and Life Sciences
NY AG Probes $35B Capital One-Discover Merger: What’s at Stake?

NY AG Probes $35B Capital One-Discover Merger: What’s at Stake?

  • October 24, 2024
  • 0 Comments
  • By Vyas Tungaturti
Regulatory Scrutiny: The proposed $35 billion merger between Capital One and Discover faces intense regulatory scrutiny from the New York Attorney General and federal regulators due to potential...
Posted in Big Deal, Deal Drama, Financial Services
WeWork’s $77M Bid Deemed Fraudulent: Key Trial Takeaways

WeWork’s $77M Bid Deemed Fraudulent: Key Trial Takeaways

  • October 22, 2024
  • 0 Comments
  • By Vyas Tungaturti
Fraudulent Bid Verdict: A Manhattan federal jury declared WeWork's $77 million bid as fraudulent, marking a critical juncture in the company's tumultuous history. Market Manipulation Allegations:...
Posted in Deal Drama, Financial Services

Posts navigation

Older posts
Newer posts

CorpDev.Org

24×7 real time deals updates for everyone associated with deals.  Bookmark the page!

Daily M&A/PE News In 5 Min

Recent Posts

  • Blackstone Abandons €2.5 Billion Pursuit of Ströer as Valuation Gaps Persist
  • Brookfield Bets on Global Air Cargo With $1.2 Billion WFC Acquisition
  • Blackstone and Google Launch $25 Billion AI Infrastructure Venture to Meet Exploding Data Center Demand
  • Paramount Readies $49 Billion Debt Sale as Warner Bros. Merger Enters Final Sprint
  • NextEra Energy’s $400 Billion Play for Dominion: Consolidation in the Age of AI

Categories

  • AI Diligence Platform
  • Expert Deal Services
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities
  • About CorpDev.Org
  • Editorial Standards

Daily M&A/PE News In 5 Min

Deals by month

  • May 2026 (47)
  • April 2026 (27)
  • March 2026 (63)
  • February 2026 (68)
  • January 2026 (138)
  • December 2025 (139)
  • August 2025 (14)
  • July 2025 (78)
  • June 2025 (161)
  • May 2025 (163)
  • April 2025 (86)
  • January 2025 (53)
  • November 2024 (62)
  • October 2024 (102)
  • September 2024 (97)
  • August 2024 (165)
  • July 2024 (20)
  • March 2023 (7)
  • November 2022 (41)
  • October 2022 (89)
  • September 2022 (190)
  • August 2022 (80)
  • July 2022 (2)
  • June 2022 (79)
  • May 2022 (1)

Copyrights belong to 'Sources' referred to in each article, unless the articles are originally published by CorpDev.org in which case the copyright belongs to CorpDev.org